Based on these observations, authors suggested that NLRP3 regulates the expression of cathelicidin and other AMPs and affects estrogen signalling in bladder epithelial cells, leaving the question of NLRP3-based therapies for preventing or treating UTI for further investigation. Here, NLRP3 is linked to bacterial urinary tract infection.